In case you missed our poster presentations at this year's Society of Toxicology Annual Meeting, here is a new opportunity. Register to get the latest updates on the GARD™ assays and how they can be used to fill in data gaps for skin sensitizing hazard and potency assessment. The webinar will last around 30 minutes, followed by […]
Determining if a new cosmetic product, pharmaceutical ingredient, or chemical substance is harmful to humans is a key prerequisite for product safety and consumer protection. Traditionally, skin sensitization testing relied on animal models, but these approaches are expensive, time consuming and raise ethical questions, while only offering limited human relevance and accuracy. SenzaGen has developed […]
In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for qualitative and quantitative skin sensitizing potency assessment, filling in data gaps in safety testing projects. The webinar will last around 30 minutes, followed by a live Q&A. Even If you cannot attend the live event, […]
This presentation will introduce GARDskin Dose-Response assay, a novel approach for the assessment of relative skin sensitizing potency on a continuous scale. Results demonstrate that induction of toxicity pathways in GARDskin Dose-Response appears to be highly dose-dependent, and the lowest concentration required to induce a positive classification in the assay correlates strongly and significantly with […]
11th World Congress on Alternatives and Animal Use in the Life Sciences 23 August - 2 September 2021 | Virtual Congress Posters open for viewing: Aug 10 - Sep 2 # P471 Abstract ID 961 Quantitative sensitizing potency assessment using GARDskin Dose-Response Dr Henrik Johansson # P140 Abstract ID 334 The GARDpotency assay for […]
User cases on hazard and potency assessment Given the huge interest in our previous webinar on GARD user cases, we are pleased to offer you a new opportunity to hear how our customers use GARD to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices. Key topics We will provide […]
Eurotox 2021 Virtual Congress 27 September - 1 October 🌎Industry symposium hosted by SenzaGen Sep 29, 17.30 - 18.30 Filling data gaps in skin sensitization testing: in vitro hazard and potency assessments using GARD Dr Andy Forreryd Dr Henrik Johansson GARDskin and GARDpotency: a proof of concept study to investigate the applicability domain for […]
The international innovation fair for cosmetic and perfume industry October 13-14 | Carrousel du Louvre, Paris | Booth: S4 Meet SenzaGen and partners PKDerm, GenEvolutioN, WatchFrog and CEHTRA at Cosmetic 360, the international innovation fair for the cosmetic and perfume industry, to find out about our latest innovations for safety and efficacy evaluation of cosmetics and ingredients. […]
In this webinar, the speakers will discuss the uses of in vitro assays as a part of the risk assessment and biological evaluation for the following endpoints: cytotoxicity, skin irritation and skin sensitization. Key topics The presentation will introduce biological evaluation and biocompatibility testing of medical devices, with focus on in vitro assays for skin irritation and skin sensitization now implemented in […]
Filling data gaps in skin sensitization testing: In vitro hazard and potency assessment using GARD In case you missed SenzaGen's industry symposium at this year's Eurotox Virtual Congress, here is a new opportunity! Together with guest speakers from Corteva Agriscience and Essity Hygiene & Health, we will present customer cases where the in vitro GARD assays have […]
